Berkshire Hathaway Inc.
BRK-B
$485.52
+0.12%
Berkshire Hathaway Inc. is a multinational conglomerate holding company that operates through a vast array of subsidiaries across insurance, freight rail transportation, utilities, manufacturing, services, and retailing. It is a quintessential value investment vehicle, distinct for its decentralized management structure, massive equity portfolio, and the stewardship of Warren Buffett and Charlie Munger, which has cultivated a reputation as a fortress of financial stability and capital allocation. The current investor narrative revolves around the post-Buffett succession planning, the performance of its massive operating businesses in a potentially slowing economic environment, and its ability to deploy its enormous cash hoard into value-accretive investments, with recent quarterly results showing mixed operational performance against a backdrop of significant market volatility.…
BRK-B
Berkshire Hathaway Inc.
$485.52
Investment Opinion: Should I buy BRK-B Today?
Rating: Hold. The core thesis is that BRK-B represents a financially robust but operationally sluggish conglomerate trading at a reasonable valuation, lacking a near-term catalyst to reverse its pronounced underperformance.
Supporting Evidence: The stock trades at a trailing P/E of 16.19x, which is below its own recent historical average, suggesting it is not overvalued. However, the forward P/E of 21.75x signals expected earnings contraction. Revenue growth is negative (-7.13% YoY in Q4), and profitability, while strong on an absolute basis (20.37% net margin), is highly volatile quarter-to-quarter. The one available analyst (UBS) maintains a Buy rating, but the lack of a consensus target price limits upside conviction.
Risks & Conditions: The two biggest risks are 1) continued earnings volatility and top-line stagnation invalidating the value proposition, and 2) a failure to deploy capital effectively, leading to perpetual underperformance. This Hold rating would upgrade to a Buy if the stock's P/E compresses further toward 14x on sustained earnings, or if the company announces a major accretive acquisition or a significant acceleration in share buybacks. It would downgrade to a Sell if revenue decline accelerates beyond 10% or if the price breaks decisively below the $455 support level. The stock is currently fairly valued relative to its own history but lacks the growth catalyst to be considered undervalued.
Sign up to view all
BRK-B 12-Month Price Forecast
BRK-B is a classic 'value trap' candidate—financially sound and reasonably priced but lacking a catalyst. The neutral stance reflects the tug-of-war between its defensive, cash-generating qualities and its clear operational and momentum challenges. Confidence is medium due to the high earnings volatility and limited analyst coverage, which reduces forecasting precision. The stance would upgrade to bullish on evidence of consistent operational execution (e.g., two consecutive quarters of revenue growth) or a major capital deployment announcement. It would turn bearish on a confirmed breakdown below $455, signaling the value floor has broken.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Berkshire Hathaway Inc.'s 12-month outlook, with a consensus price target around $631.18 and implied upside of +30.0% versus the current price.
Average Target
$631.18
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$388 - $631
Analyst target range
Insufficient analyst coverage available. The provided data indicates coverage from only one analyst (UBS), which has maintained a consistent 'Buy' rating across multiple dates from 2024 through late 2025. The lack of a broad analyst consensus, average target price, or target range is typical for Berkshire Hathaway, as its unique structure and size make it less reliant on traditional sell-side coverage. This limited coverage implies the stock is primarily driven by its own fundamentals, macroeconomic factors, and the decisions of large institutional investors rather than analyst sentiment. It can lead to periods of higher volatility and less efficient price discovery compared to heavily covered mega-cap peers, as news and earnings are interpreted by a smaller pool of professional voices.
Bulls vs Bears: BRK-B Investment Factors
The evidence currently tilts bearish, primarily due to the stock's severe technical underperformance, volatile fundamentals, and the market's implied expectation of an earnings decline via a higher forward P/E. The most critical tension in the investment debate is between Berkshire's undeniable long-term financial fortress characteristics—its strong balance sheet and cash generation—and its near-term inability to demonstrate consistent operational growth or attract investor capital in a market favoring high-growth themes. The resolution of this tension hinges on whether the company can deploy its massive cash hoard into value-accretive investments that reignite earnings growth and investor confidence.
Bullish
- Fortress Balance Sheet: Berkshire's financial position is exceptionally strong, with a debt-to-equity ratio of just 0.19 and a current ratio of 6.75, indicating ample liquidity to weather economic downturns. The company generated $25.04 billion in TTM free cash flow, providing significant capital for investments or buybacks without external financing.
- Attractive Valuation vs. History: The stock trades at a trailing P/E of 16.19x, which is below its own recent historical range that has seen peaks above 60x. This suggests the market has priced in significant pessimism, offering a potential margin of safety if earnings stabilize.
- Massive Cash Generation: Despite recent revenue volatility, the company maintains robust profitability, with a Q4 2025 net margin of 20.37%. The trailing twelve-month free cash flow of $25.04 billion underscores the underlying cash-generating power of its diversified operating businesses.
- Low Market Correlation: With a beta of 0.699, BRK-B is approximately 30% less volatile than the broader market, providing a defensive characteristic in portfolio construction. This low beta has historically offered downside cushion during market sell-offs.
Bearish
- Severe Underperformance & Downtrend: BRK-B has declined 10.79% over the past year, underperforming the S&P 500 by a staggering 39.83 percentage points. The stock is trading just 10.3% above its 52-week low of $455.19, reflecting persistent negative sentiment and a lack of buying interest.
- Inconsistent Revenue & Earnings: Q4 2025 revenue declined 7.13% year-over-year, and quarterly net income has been highly volatile, ranging from $4.60 billion in Q1 2025 to $30.80 billion in Q3 2025. This lack of operational momentum raises questions about near-term growth visibility.
- Forward P/E Suggests Earnings Decline: The forward P/E of 21.75x is significantly higher than the trailing P/E of 16.19x, implying the market expects a meaningful drop in future earnings. This valuation disconnect signals skepticism about the sustainability of recent profit levels.
- Limited Analyst Coverage & Catalysts: With only one analyst (UBS) providing coverage, the stock lacks the broad analyst sentiment and price target consensus that typically drives institutional interest. This can lead to inefficient price discovery and periods of heightened volatility.
BRK-B Technical Analysis
The stock is in a pronounced downtrend and is currently trading near the lows of its recent range. Over the past year, BRK-B has declined by 10.79%, significantly underperforming the S&P 500, which gained 29.04%, resulting in a severe relative strength deficit of -39.83%. The current price of $473.16 sits just 10.3% above its 52-week low of $455.19 and 12.7% below its 52-week high of $542.07, positioning it in the lower quartile of its annual range, which suggests the stock is in a zone of potential value but also reflects persistent selling pressure and negative sentiment. Recent short-term momentum shows continued weakness, with the stock down 1.15% over the past month and 1.56% over the past three months, both periods during which the broader market (SPY) posted gains of 9.98% and 4.14%, respectively. This divergence highlights severe underperformance and a lack of buying interest, indicating the downtrend remains intact without signs of a near-term reversal. Key technical levels are clearly defined, with immediate support at the 52-week low of $455.19 and resistance at the recent high near $513.81 from late November 2025. A breakdown below $455 would signal a new leg down, while a sustained move above $500 is needed to suggest a meaningful recovery. The stock's beta of 0.699 indicates it is approximately 30% less volatile than the market, which, while providing some downside cushion during sell-offs, has not prevented significant absolute price declines in the current environment.
Beta
0.62
0.62x market volatility
Max Drawdown
-14.9%
Largest decline past year
52-Week Range
$455-$517
Price range past year
Annual Return
-5.1%
Cumulative gain past year
| Period | BRK-B Return | S&P 500 |
|---|---|---|
| 1m | +1.1% | +8.2% |
| 3m | -2.9% | +9.0% |
| 6m | -4.6% | +10.5% |
| 1y | -5.1% | +26.5% |
| ytd | -2.3% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BRK-B Fundamental Analysis
Revenue growth has been inconsistent and recently turned negative. For Q4 2025, revenue was $94.23 billion, representing a year-over-year decline of 7.13%. This follows a volatile pattern in prior quarters of 2025, with Q3 revenue at $94.97 billion, Q2 at $98.88 billion, and Q1 at $83.29 billion, indicating a lack of clear top-line momentum. The revenue segment data shows the Insurance Group generated $26.41 billion, Manufacturing $19.71 billion, and Service/Retailing $21.37 billion, but without sequential growth rates, the driver of the overall decline is unclear, pointing to broad-based softness. Profitability remains robust on an absolute basis but has shown volatility quarter-to-quarter. Q4 2025 net income was $19.20 billion, yielding a net margin of 20.37%, which is strong. However, this compares to a significantly higher net income of $30.80 billion in Q3 2025 (32.43% margin) and $12.37 billion in Q2 (12.51% margin). The gross margin for Q4 was 23.01%, down from 23.29% in Q3, indicating some margin compression in the most recent period, though the operating margin held at 14.48%. The balance sheet and cash flow position remain exceptionally strong, underpinning the company's financial fortress reputation. The debt-to-equity ratio is a conservative 0.19, and the current ratio is a very healthy 6.75, indicating ample liquidity. Trailing twelve-month free cash flow is a substantial $25.04 billion. Return on equity for the latest period is 9.33%, which, while respectable, is below the levels seen in stronger quarters like Q3 2025 (4.41%), reflecting the earnings volatility. The company generates massive internal cash, reducing reliance on external financing.
Quarterly Revenue
$94.2B
2025-12
Revenue YoY Growth
-0.07%
YoY Comparison
Gross Margin
+0.23%
Latest Quarter
Free Cash Flow
$25.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BRK-B Overvalued?
Given the consistently positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing twelve-month PE ratio is 16.19x, while the forward PE is 21.75x. The higher forward multiple suggests the market is anticipating an earnings decline, which aligns with the recent quarterly net income volatility and the negative revenue growth in Q4. Comparing to industry averages is challenging as Berkshire is a unique conglomerate, but its valuation is often viewed relative to its own history and the market. The stock's Price-to-Book (PB) ratio of 1.51x and Price-to-Sales (PS) ratio of 2.92x provide additional context, though the PE is most relevant. Historically, the stock's own valuation provides key insight. The current trailing PE of 16.19x is below the historical range observed in the provided data over the past several years, which has seen peaks above 60x (Q1 2025) and troughs near 5x (Q4 2023). It is notably lower than the 21.19x seen in Q2 2025 and the 14.12x from Q4 2025. Trading below its recent historical average suggests the market has priced in concerns about earnings quality and growth, potentially offering a margin of safety if the core business proves resilient.
PE
16.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -52x~62x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Berkshire's primary financial risk is not solvency but earnings volatility and growth stagnation. Quarterly net income has fluctuated wildly from $4.6 billion to $30.8 billion over the past year, and Q4 2025 revenue declined 7.13% YoY. This inconsistency makes forecasting difficult and could lead to multiple compression if the market perceives a structural slowdown. While the balance sheet is a fortress (D/E 0.19), the risk is that the enormous cash pile ($25B+ FCF) fails to find high-return deployment opportunities, leading to suboptimal capital allocation and a drag on returns.
Market & Competitive Risks: The key market risk is prolonged valuation compression. The stock's severe underperformance (-39.83% vs. SPY over 1 year) suggests it is deeply out of favor, potentially facing a sector rotation away from value/conglomerate structures. Its low beta (0.699) has not protected it from absolute price declines in the current environment. A competitive risk is the potential for its insurance and railroad businesses to face cyclical or secular headwinds that pressure margins, which showed early signs of compression with Q4 gross margin dipping to 23.01% from 23.29% in Q3.
Worst-Case Scenario: The worst-case scenario involves a continuation of the current downtrend, exacerbated by a broader economic slowdown that hits Berkshire's cyclical operating businesses (rail, manufacturing, retail) and its equity portfolio simultaneously. This could trigger a breakdown below the key $455.19 support (the 52-week low), leading to a new leg down as technical selling accelerates. A realistic downside from the current price of $473.16 could be a 15-20% decline to the $380-$400 range, based on a further de-rating of the P/E multiple towards the lower end of its historical spectrum, representing a potential loss of approximately $70-$90 per share.
FAQ
The key risks are, in order of severity: 1) Operational Stagnation Risk: Volatile and recently declining revenue (-7.13% YoY in Q4) coupled with wildly fluctuating quarterly net income. 2) Capital Deployment Risk: The failure to effectively deploy its $25+ billion in annual free cash flow into high-return investments, leading to subpar shareholder returns. 3) Sentiment & Technical Risk: The stock is in a pronounced downtrend and severely underperforming the market, which can become a self-fulfilling prophecy. 4) Succession Risk: Long-term uncertainty surrounding leadership and capital allocation philosophy after Warren Buffett.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $480 and $520, reflecting range-bound action as operational volatility persists. The Bull Case (25% probability) targets $542 to $580, driven by a major accretive acquisition or a return to consistent growth. The Bear Case (15% probability) warns of a drop to $420-$455 if operational headwinds intensify and the stock breaks key support. The base case is most likely, predicated on the assumption that Berkshire's earnings power remains intact but unexciting, and no major catalyst emerges to break the current negative sentiment.
BRK-B appears fairly valued relative to its own recent history but may be undervalued on an absolute basis if its earnings power is sustainable. The trailing P/E of 16.19x is below its historical peaks above 60x, suggesting the market is not overpaying. However, the higher forward P/E of 21.75x implies the market expects earnings to decline. Compared to a pure value benchmark, the P/E is not cheap, but for a company of its quality and financial strength, it is not excessive. The valuation implies the market expects stagnant growth and has priced in significant skepticism.
BRK-B is a good buy for a specific type of investor: one with a long-term horizon who prioritizes capital preservation and is comfortable with potential underperformance during market rallies. The stock trades at a reasonable trailing P/E of 16.19x and boasts a fortress balance sheet. However, its severe 1-year underperformance (-39.83% vs. SPY) and volatile quarterly earnings create near-term uncertainty. It is not a good buy for investors seeking rapid growth or short-term gains, as it lacks a clear near-term catalyst.
BRK-B is unequivocally suitable for long-term investment, with a suggested minimum holding period of 3-5 years. Its low beta (0.699) and diversified business model are designed for compounding wealth over full market cycles, not for short-term trading. The stock's lack of momentum, severe recent underperformance, and earnings volatility make it a poor candidate for short-term speculation. Long-term investors can look past quarterly noise and benefit from the company's capital allocation over time, while short-term traders would likely be frustrated by its lack of directional catalysts.